Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Larry Liebman who wrote (340)	12/31/1998 11:36:00 PM
From: Mike McFarland	Respond to of 1073

OFF TOPIC/re Janus Global Life Sciences yeah, I saw that too, called for the perspectus and forms. Here is a funny story...around ten years ago when I first got a job I was making only about 15k a year... but I lived in a small town in Nevada and had no way to spend my money. The dow was around 3000 if I remember right, and I had all my forms ready to send in to Janus to start investing. This would have been after the mini crash-- a year or two after the October 87 crash. Anyway, I had a check written out and everything and for some reason I decided I was too poor to start investing...so I transfered the cash to savings and didn't start an ira until several years later. whoops. (fyi I am not some nut who stays online on New Year's Eve...I snuck this post in from work, where I am stuck this holiday) --Mike

To: Larry Liebman who wrote (340)	1/1/1999 12:42:00 PM
From: scaram(o)uche	Respond to of 1073

Larry: When I learned about the Science paper, I bought a bit more before the close at 1 3/4. >>BTW, I had an extremely interesting talk with the ARIA CFO today. Had I not a slug of stock/warrants I would have bought more at $1 1/2.<< A bottomless convertible in a company with the scienctific foresight of ARIA? By any measure, LaMarche has been one of biotech's worst performing managers. Perhaps he's been good but handcuffed, as the ultimate responsibility lies with Berger. In any event, their combined score is a one on a scale of one to ten. >>Here's to the renaissance of biotechs in '99!!!!<< The value assigned to innovation at this time is absurdly low. It should come in '99, but we will profit handsomely from mucking down here in the second- and third-tiers. >>They're starting a new fund to be known as "Global Life Sciences"<< Hurray! More, more! Thanks! Rick